Blood eosinophil-guided treatment of COPD: the STARR2 study

2 Apr 2024

At the TSANZ 2024 annual meeting, Dr Sanjay Ramakrishnan discussed the implications for biomarker-guided treatment of COPD exacerbations based on results from the STARR2 study. 

Already a member?

Login to keep reading.

OR
Email me a login link